Acadia Pharmaceuticals Inc. Forecast and Target Price
$19.6
Acadia Pharmaceuticals Inc. (ACAD) Share Price Forecast
Currently 26 wall-street analysts regularly analyze the financials of Acadia Pharmaceuticals Inc. on a frequent basis to provide recommendations along with target share price. 26 analysts offering 12-month price forecasts for Acadia Pharmaceuticals Inc. (ACAD) have a share price target of $24.7. This median of share price forecast represents a 26.02% upside from the latest price of $19.6 as on 06.03.25.
Acadia Pharmaceuticals Inc. (ACAD) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Acadia Pharmaceuticals Inc. (ACAD) share price will touch around $24.7 in next 12-months.
Acadia Pharmaceuticals Inc. (ACAD) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Acadia Pharmaceuticals Inc.'s share price and its median forecast price. As on 06.03.25, the difference is -40.76%
Acadia Pharmaceuticals Inc. (ACAD): Difference between Current Price & Median Forecasted Price
Acadia Pharmaceuticals Inc. (ACAD) Share Price : Analyst Recommendation
Based on 26 analysts tracking and researching Acadia Pharmaceuticals Inc. (ACAD) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 14 | 13 | 13 |
| Outperform | 6 | 6 | 6 |
| Hold | 6 | 7 | 6 |
| Underperform | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 |